This company listing is no longer active
Salud financiera de hoja de balance de Liminal BioSciences
Salud financiera controles de criterios 5/6
Liminal BioSciences has a total shareholder equity of CA$36.2M and total debt of CA$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CA$50.5M and CA$14.3M respectively.
Información clave
0%
Ratio deuda-patrimonio
CA$0
Deuda
| Ratio de cobertura de intereses | n/a |
| Efectivo | CA$37.14m |
| Patrimonio | CA$36.21m |
| Total pasivo | CA$14.25m |
| Activos totales | CA$50.46m |
Actualizaciones recientes sobre salud financiera
Recent updates
Análisis de la situación financiera
Pasivos a corto plazo: PJ2's short term assets (CA$41.3M) exceed its short term liabilities (CA$10.1M).
Pasivo a largo plazo: PJ2's short term assets (CA$41.3M) exceed its long term liabilities (CA$4.1M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: PJ2 is debt free.
Reducción de la deuda: PJ2 has no debt compared to 5 years ago when its debt to equity ratio was 60.7%.
Hoja de balance
Análisis de cash runway
En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.
Cash runway estable: PJ2 has sufficient cash runway for more than a year based on its current free cash flow.
Pronóstico de cash runway: PJ2 has less than a year of cash runway if free cash flow continues to grow at historical rates of 11.4% each year.